<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00212264</url>
  </required_header>
  <id_info>
    <org_study_id>DK60044 (completed)</org_study_id>
    <nct_id>NCT00212264</nct_id>
  </id_info>
  <brief_title>Conservative Treatment of Postprostatectomy Incontinence</brief_title>
  <official_title>Conservative Treatment of Postprostatectomy Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to test the effectiveness, impact on quality of life,
      and durability of non-surgical therapies for incontinence persisting at least one year after
      surgery. The study is a a prospective, controlled, randomized trial comparing an 8-week,
      multi-component behavioral training program (pelvic floor muscle exercises, self-monitoring
      with bladder diaries, regular office visits, bladder control techniques, and fluid
      management) to the same program with the addition of biofeedback and pelvic muscle electrical
      stimulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this project is to test the effectiveness, impact on quality of life,
      and durability of conservative therapies for persistent post-prostatectomy urinary
      incontinence in a prospective, controlled, randomized trial comparing an 8-week,
      multi-component behavioral training program (pelvic floor muscle exercises, self-monitoring
      with bladder diaries, regular office visits, bladder control techniques, and fluid
      management) to the same program with the addition of biofeedback and pelvic muscle electrical
      stimulation.

      The second purpose of the study is to examine and compare the cost-effectiveness of the
      8-week, multi-component behavioral training program to the same program with the addition of
      biofeedback and pelvic floor electrical stimulation.

      Prostate cancer is the most common internal cancer in men in the United States. The most
      common treatment for early disease is radical prostatectomy, the removal of the prostate
      gland. The two most common sequelae of prostatectomy are incontinence and erectile
      dysfunction. The incontinence improves and often resolves in the first year after
      prostatectomy, but surveys of patients show that 40% of men have incontinence severe enough
      to require pads 1 and 2 years after their surgery. There are currently no randomized,
      controlled studies of non-surgical treatments for persistent post-prostatectomy incontinence.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Incontinence Episodes on Bladder Diary</measure>
    <time_frame>2 months</time_frame>
    <description>[(Baseline incontinence episodes minus 2-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change in Incontinence Episodes Per Week on Bladder Diary</measure>
    <time_frame>1 year</time_frame>
    <description>[(Baseline incontinence episodes minus 12-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">208</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral Therapy Plus Technologies</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No treatment control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Therapy</intervention_name>
    <description>Pelvic Floor Muscle Exercises and Bladder control strategies</description>
    <arm_group_label>Behavioral Therapy</arm_group_label>
    <arm_group_label>Behavioral Therapy Plus Technologies</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pelvic Floor Electrical Stimulation</intervention_name>
    <description>Pelvic Floor Electrical Stimulation daily for 8 weeks</description>
    <arm_group_label>Behavioral Therapy Plus Technologies</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Biofeedback</intervention_name>
    <description>Pelvic Floor Muscle training via biofeedback</description>
    <arm_group_label>Behavioral Therapy Plus Technologies</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Treatment</intervention_name>
    <description>No treatment</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Involuntary loss of urine that started immediately after radical prostatectomy and has
             persisted for at least one year.

          2. One-week bladder diary with interpretable data and at least two incontinence episodes

        Exclusion Criteria:

          1. Any unstable medical condition, particularly decompensated congestive heart failure,
             history of malignant arrhythmias, or unstable angina

          2. Cardiac pacemaker or implanted cardiac defibrillator

          3. Current use of anticholinergic agents for detrusor instability

          4. Folstein's Mini-Mental State Exam score below 24 (impaired mental status)

          5. One-week bladder diary with continual leakage - defined as always being damp or wet or
             unable to quantitate individual accidents.

          6. Poorly controlled diabetes, defined as (glycosylated hemoglobin &gt; 9 within last 3
             months).

          7. Hematuria on microscopic examination. Enrollment will be permitted after urologic
             evaluation.

          8. Urodynamic evaluation: Post-void residual volume greater than 200 mL
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia S Goode, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Goode PS, Burgio KL, Johnson TM 2nd, Clay OJ, Roth DL, Markland AD, Burkhardt JH, Issa MM, Lloyd LK. Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA. 2011 Jan 12;305(2):151-9. doi: 10.1001/jama.2010.1972.</citation>
    <PMID>21224456</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <results_first_submitted>October 7, 2014</results_first_submitted>
  <results_first_submitted_qc>March 21, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 11, 2016</results_first_posted>
  <last_update_submitted>March 21, 2016</last_update_submitted>
  <last_update_submitted_qc>March 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</investigator_affiliation>
    <investigator_full_name>Patricia Goode, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>urinary incontinence</keyword>
  <keyword>therapy</keyword>
  <keyword>prostatectomy</keyword>
  <keyword>prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Behavioral Therapy</title>
          <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies</description>
        </group>
        <group group_id="P2">
          <title>Behavioral Therapy Plus Technologies</title>
          <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies
Pelvic Floor Electrical Stimulation: Pelvic Floor Electrical Stimulation daily for 8 weeks
Biofeedback: Pelvic Floor Muscle training via biofeedback</description>
        </group>
        <group group_id="P3">
          <title>Placebo Comparator</title>
          <description>No treatment control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="70"/>
                <participants group_id="P3" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="54"/>
                <participants group_id="P3" count="64"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Behavioral Therapy</title>
          <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies</description>
        </group>
        <group group_id="B2">
          <title>Behavioral Therapy Plus Technologies</title>
          <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies
Pelvic Floor Electrical Stimulation: Pelvic Floor Electrical Stimulation daily for 8 weeks
Biofeedback: Pelvic Floor Muscle training via biofeedback</description>
        </group>
        <group group_id="B3">
          <title>Placebo Comparator</title>
          <description>No treatment control</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="70"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="68"/>
            <count group_id="B4" value="208"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="7.5"/>
                    <measurement group_id="B2" value="66.8" spread="7.0"/>
                    <measurement group_id="B3" value="66.9" spread="7.7"/>
                    <measurement group_id="B4" value="66.7" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="70"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Incontinence Episodes per Week</title>
          <units>Incontinence Episodes per Week</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.1" spread="22.0"/>
                    <measurement group_id="B2" value="25.6" spread="26.0"/>
                    <measurement group_id="B3" value="24.8" spread="19.9"/>
                    <measurement group_id="B4" value="26.2" spread="22.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Incontinence Episodes on Bladder Diary</title>
        <description>[(Baseline incontinence episodes minus 2-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
        <time_frame>2 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Behavioral Therapy</title>
            <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy Plus Technologies</title>
            <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies
Pelvic Floor Electrical Stimulation: Pelvic Floor Electrical Stimulation daily for 8 weeks
Biofeedback: Pelvic Floor Muscle training via biofeedback</description>
          </group>
          <group group_id="O3">
            <title>Placebo Comparator</title>
            <description>No treatment control</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Incontinence Episodes on Bladder Diary</title>
          <description>[(Baseline incontinence episodes minus 2-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
          <units>% change in episodes per week</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55" lower_limit="44" upper_limit="66"/>
                    <measurement group_id="O2" value="51" lower_limit="37" upper_limit="65"/>
                    <measurement group_id="O3" value="24" lower_limit="10" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.001</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Incontinence Episodes Per Week on Bladder Diary</title>
        <description>[(Baseline incontinence episodes minus 12-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
        <time_frame>1 year</time_frame>
        <population>This outcome was to measure treatment durability. The no-treatment control group completed the study after the primary outcome was collected at 2 months. At that time, they were offered treatment for this burdensome condition outside the study. Only the 2 active treatment groups continued in the study for 1 full year.</population>
        <group_list>
          <group group_id="O1">
            <title>Behavioral Therapy</title>
            <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Therapy Plus Technologies</title>
            <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies
Pelvic Floor Electrical Stimulation: Pelvic Floor Electrical Stimulation daily for 8 weeks
Biofeedback: Pelvic Floor Muscle training via biofeedback</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Incontinence Episodes Per Week on Bladder Diary</title>
          <description>[(Baseline incontinence episodes minus 12-month incontinence episodes)/baseline incontinence episodes] x 100%</description>
          <population>This outcome was to measure treatment durability. The no-treatment control group completed the study after the primary outcome was collected at 2 months. At that time, they were offered treatment for this burdensome condition outside the study. Only the 2 active treatment groups continued in the study for 1 full year.</population>
          <units>% change in episodes per week</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="40" upper_limit="61"/>
                    <measurement group_id="O2" value="59" lower_limit="45" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.32</p_value>
            <method>t-test, 1 sided</method>
            <method_desc>Note that the no-treatment control group completed the study after 2 months and was not included in this analysis of treatment effect durability.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Behavioral Therapy</title>
          <description>Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies</description>
        </group>
        <group group_id="E2">
          <title>Behavioral Therapy Plus Technologies</title>
          <description>Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
Behavioral Therapy: Pelvic Floor Muscle Exercises and Bladder control strategies
Pelvic Floor Electrical Stimulation: Pelvic Floor Electrical Stimulation daily for 8 weeks
Biofeedback: Pelvic Floor Muscle training via biofeedback</description>
        </group>
        <group group_id="E3">
          <title>Placebo Comparator</title>
          <description>No treatment control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="70"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Irritation of Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="70"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Patricia S Goode, MD</name_or_title>
      <organization>University of Alabama at Birmingham</organization>
      <phone>2055587064</phone>
      <email>pgoode@uabmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

